79/100BMorgan Stanley stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Morgan Stanley is 212.00, 16.9% above the current price of 181.42. Their targets range from 195.00 to 236.00.
Of the 17 firms that rated Morgan Stanley in the past 12 months, 8 rate it buy or strong buy, 8 hold and 1 sell or strong sell (each firm at its latest rating): a Hold consensus.
Analysts' 1-year price targets range from 195.00 to 236.00, with an average of 212.00.
| Buy | 8 | |
| Hold | 8 | |
| Sell | 1 |
12-month price target
| Highest target | 236.00 |
| Average target | 212.00 |
| Lowest target | 195.00 |
| Current price | 181.42 |
Morgan Stanley price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Morgan Stanley price target and rating?
How analysts rate Morgan Stanley, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
8 of 17 firms rate it buy now, against 6 of 13 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Morgan Stanley analyst upgrades, downgrades and price targets
The latest rating change came on 17 July 2026, when Freedom Broker upgraded Morgan Stanley from Hold to Buy. The most recent new target came from Wells Fargo on 15 October 2026: 217.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 15 Oct 2026 | Wells Fargo Mike Mayo | Reiterated · Equal Weight | 223.00 → 217.00 | -2.7% | 181.61 |
| 15 Oct 2026 | RBC Capital Gerald Cassidy | Reiterated · Sector Perform | 243.00 → 195.00 | -19.8% | 181.61 |
| 14 Oct 2026 | Morgan Stanley Richard Ramsden | — | 215.00 → 200.00 | -7.0% | 181.61 |
| 5 Oct 2026 | UBS Erika Najarian | Reiterated · Buy | 260.00 → 236.00 | -9.2% | 190.31 |
| 25 Sept 2026 | Wells Fargo | Reiterated · Equal Weight | 240.00 → 223.00 | -7.1% | 196.34 |
| 3 Aug 2026 | UBS | Reiterated · Buy | 255.00 → 260.00 | +2.0% | 210.64 |
| 21 Jul 2026 | Morgan Stanley Saul Martinez | — | 235.00 → 215.00 | -8.5% | 210.97 |
| 20 Jul 2026 | RBC Capital Gerard Cassidy | — | 207.00 → 243.00 | +17.4% | 215.48 |
| 17 Jul 2026 | Morgan Stanley | — | 195.00 → 235.00 | +20.5% | 218.37 |
| 17 Jul 2026 | Freedom Broker | Upgraded · Hold → Buy | — | — | — |
| 16 Jul 2026 | Morgan Stanley | — | 262.00 → 195.00 | -25.6% | 228.42 |
| 16 Jul 2026 | Morgan Stanley | — | 241.00 → 262.00 | +8.7% | 228.42 |
| 16 Jul 2026 | Wells Fargo | Reiterated · Equal Weight | 200.00 → 240.00 | +20.0% | 228.42 |
| 15 Jul 2026 | Morgan Stanley | — | 250.00 → 241.00 | -3.6% | 228.42 |
| 7 Jul 2026 | Morgan Stanley | — | 233.00 → 250.00 | +7.3% | 221.09 |
| 7 Jul 2026 | UBS | Reiterated · Buy | 165.00 → 255.00 | +54.5% | 222.79 |
| 6 Jul 2026 | Morgan Stanley Richard Ramsden | — | 187.00 → 233.00 | +24.6% | 213.92 |
| 30 Jun 2026 | Oppenheimer | Downgraded · Perform → Underperform | — | — | — |
| 12 Jun 2026 | Morgan Stanley | — | 194.00 → 187.00 | -3.6% | 212.66 |
| 8 May 2026 | Morgan Stanley | — | 205.00 → 194.00 | -5.4% | 190.17 |
| 16 Apr 2026 | Wells Fargo Mike Mayo | Reiterated · Equal Weight | 177.00 → 200.00 | +13.0% | 191.60 |
| 16 Apr 2026 | Morgan Stanley Richard Ramsden | — | 225.00 → 205.00 | -8.9% | 191.60 |
| 16 Apr 2026 | Morgan Stanley Ebrahim Poonawala | — | 230.00 → 225.00 | -2.2% | 191.60 |
| 16 Apr 2026 | Morgan Stanley Jason Goldberg | — | 218.00 → 230.00 | +5.5% | 191.60 |
| 16 Apr 2026 | Morgan Stanley Christopher McGratty | — | 220.00 → 218.00 | -0.9% | 191.60 |
| 7 Apr 2026 | UBS | Upgraded · Neutral → Buy | — | — | — |
| 16 Jan 2026 | Morgan Stanley | — | 210.00 → 220.00 | +4.8% | 192.04 |
| 16 Jan 2026 | Morgan Stanley | — | 132.00 → 210.00 | +59.1% | 191.29 |
| 16 Jan 2026 | RBC Capital Gerald Cassidy | Reiterated · Sector Perform | 207.00 | — | 191.29 |
| 7 Jan 2026 | Wolfe Research Steven Chubak | — | 198.00 → 211.00 | +6.6% | 185.33 |
| 7 Jan 2026 | Morgan Stanley Saul Martinez | — | 190.00 → 132.00 | -30.5% | 185.87 |
| 6 Jan 2026 | Morgan Stanley | — | 219.00 → 190.00 | -13.2% | 186.58 |
| 5 Jan 2026 | Morgan Stanley | — | 202.00 → 219.00 | +8.4% | 181.90 |
| 17 Dec 2025 | Morgan Stanley | — | 184.00 → 202.00 | +9.8% | 176.51 |
| 24 Nov 2025 | Wolfe Research Steven Chubak | Upgraded · Peer Perform → Outperform | 198.00 | — | 158.17 |
Morgan Stanley EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Morgan Stanley's EPS to grow 13.7% a year until 2028. Over the last 5 years it grew 9.6% a year, and over the last 3 years 18.4%.
Analysts expect Morgan Stanley's revenue to grow 11.7% a year until 2028. Over the last 5 years it grew 7.6% a year, and over the last 3 years 9.5%.
Revenue
EPS
Does Morgan Stanley beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 16.2% off the result, either way, and their revenue estimate 2.5%, over the last 12 quarters.
- EPS beats
- 88 / 110
- Revenue beats
- 64 / 107
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +15.8%
- Since
- July 1997
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 14 Oct 2026 | 2.93 | 3.03 | +3.4% | 19.93B | 20.34B | +2.1% |
| Q2 FY2026 | 15 Jul 2026 | 2.93 | 3.46 | +18.1% | 19.67B | 21.35B | +8.5% |
| Q1 FY2026 | 15 Apr 2026 | 3.02 | 3.43 | +13.6% | 19.74B | 20.58B | +4.3% |
| Q4 FY2025 | 15 Jan 2026 | 2.43 | 2.68 | +10.3% | 17.74B | 17.89B | +0.8% |
| Q3 FY2025 | 15 Oct 2025 | 2.10 | 2.80 | +33.3% | 16.69B | 17.08B | +2.4% |
| Q2 FY2025 | 16 Jul 2025 | 1.98 | 2.13 | +7.6% | 16.07B | 15.60B | -2.9% |
| Q1 FY2025 | 11 Apr 2025 | 2.21 | 2.60 | +17.6% | 16.54B | 16.52B | -0.1% |
| Q4 FY2024 | 16 Jan 2025 | 1.62 | 2.22 | +37.0% | 15.03B | 15.04B | +0.1% |
| Q3 FY2024 | 16 Oct 2024 | 1.58 | 1.88 | +19.0% | 14.35B | 14.34B | -0.1% |
| Q2 FY2024 | 16 Jul 2024 | 1.65 | 1.82 | +10.3% | 14.32B | 14.02B | -2.1% |
| Q1 FY2024 | 16 Apr 2024 | 1.66 | 2.02 | +21.7% | 14.40B | 14.22B | -1.3% |
| Q4 FY2023 | 16 Jan 2024 | 1.01 | 0.99 | -2.0% | 12.75B | 12.03B | -5.6% |
Morgan Stanley stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Morgan Stanley's earnings keep growing at the 13.7% a year analysts expect to FY2028, it would earn about 19.41 a share in FY2030. At the P/E it has traded at over the last five years (12.0 to 17.8) that is 233.48 to 345.39 a share, or 293.03 at its average P/E of 15.1. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 12.90 | 155.15 | 194.72 | 229.52 |
| FY2027 | 13.79 | 165.94 | 208.27 | 245.49 |
| FY2028 | 15.01 | 180.57 | 226.63 | 267.13 |
| FY2029 (extrapolated) | 17.07 | 205.33 | 257.70 | 303.75 |
| FY2030 (extrapolated) | 19.41 | 233.48 | 293.03 | 345.39 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 13.7% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (12.0, 15.1, 17.8).
Is Morgan Stanley stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Morgan Stanley's P/E of 14.3 is below the middle of its 5-year range (9.2 to 21.2, median 15.4). Analysts do not expect slower growth than in recent years, so it is cheaper than its usual level. Buyers pay less for each point of growth than usual: a PEG of 1.0 on expected growth against 1.6 on its median P/E and past five years' growth. At its usual P/E (15.3 × EPS of 12.68), Morgan Stanley's fair value is 193.70; the price, 181.42, is 6.3% below it. Its forward P/E, on the consensus for FY2026, is 14.1.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (9.2 and 21.2). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 14.31
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 15.38
- Five-year P/E range
- 9.2 – 21.2
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 14.07
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 1.04
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +16.9%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 194.93146Price 99.09244 | +96.7% | |
| 42.225 | 82.9546Price 42.23165 | +96.4% | |
| 186.680 | 360.82271Price 186.68451 | +93.3% | |
| 213.670 | 405.57304Price 213.67507 | +89.8% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 160.650 | 300.09225Price 160.65375 | +86.8% | |
| 165.860 | 308.95212Price 165.86442 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.